Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024
Authors:
- Joanna Kacperczyk-BartnikJKJoanna Kacperczyk-Bartnik
- Houssein El HajjHoussein El Hajj
- Nicolò BizzarriNicolò Bizzarri
- Esra BilirEBEsra Bilir
- Tibor Andrea ZwimpferTZTibor Andrea Zwimpfer
- Aleksandra Natalia StrojnaASAleksandra Natalia Strojna
- Martina Aida AngelesMAMartina Aida Angeles
- Valentina GhirardiVGValentina Ghirardi
- Charalampos TheofanakisCTCharalampos Theofanakis
- 22 July 2024
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 34 (9) , 1324-1333
Abstract
The 'Best of ESGO 2024' article includes a selection of the most highly rated original research presented during the 25th Annual Congress of the European Society of Gynaecologic Oncology (ESGO), held in Barcelona, Spain, March 7–10, 2024. Of 1218 asbtracts submitted, 35 studies presented during the best oral sessions, mini oral sessions, best three minute presentations session, and young investigator session were selected by the ESGO abstract committee and the authors of the European Network of Young Gynae Oncologists (ENYGO). There was a strong focus on the surgical treatment of early stage cervical cancer and the management of advanced or recurrent gynecological cancers using induction therapy, immunotherapy, and maintenance therapy. With this work, ENYGO and ESGO aim to focus the attention of clinicians, scientists, patients, and all stakeholders interested in gynecologic oncology on research advances in the field.Keywords
This publication has 47 references indexed in Scilit:
- Simple versus Radical Hysterectomy in Women with Low-Risk Cervical CancerNew England Journal of Medicine, 2024
- Dostarlimab for Primary Advanced or Recurrent Endometrial CancerNew England Journal of Medicine, 2023
- Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilationInternational Journal of Gynecological Cancer, 2022
- Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual MeetingInternational Journal of Gynecological Cancer, 2021
- Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial CancerJAMA Oncology, 2020
- Report from the 21st meeting of the European Society of Gynaecological Oncology (ESGO 2019)International Journal of Gynecological Cancer, 2020
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseInternational Journal of Gynecological Cancer, 2019
- Corrections to “Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”Annals of Oncology, 2018
- Report From the 20th Meeting of the European Society of Gynaecological Oncology (ESGO 2017)International Journal of Gynecological Cancer, 2018